Safety Considerations of the Use of Second Generation Antipsychotics in the Treatment of Major Depression: Extrapyramidal and Metabolic Side Effects

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|5|3|263-266

ISSN： 1574-8863

Source： Current Drug Safety, Vol.5, Iss.3, 2010-07, pp. : 263-266

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

“Salami Slicing” in Pooled Analyses of Second-Generation Antipsychotics for the Treatment of Depression

By  

Psychotherapy and Psychosomatics, Vol. 86, Iss. 3, 2017-05 ,pp. : 171-172

Karger

Access to resources Recommend Favorite

A Second Thought on Subtyping Major Depression

By  

Psychotherapy and Psychosomatics, Vol. 79, Iss. 6, 2010-09 ,pp. : 388-389

Karger

Access to resources Recommend Favorite

Objective and Subjective Extrapyramidal Side Effects in Schizophrenia: Their Relationships with Negative and Depressive Symptoms

By  

Psychopathology, Vol. 33, Iss. 3, 2000-04 ,pp. : 125-130

Karger

Access to resources Recommend Favorite

Depression in the Elderly: Pharmacologic Considerations in Treatment

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 30, Iss. 9, 1982-09 ,pp. : 581-586

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder Secondary to Second-Generation Antipsychotics

By  

Psychotherapy and Psychosomatics, Vol. 84, Iss. 3, 2015-03 ,pp. : 188-189

Karger

Access to resources Recommend Favorite